Skip to main navigation Skip to search Skip to main content

EPR22-112: Risk of prostate cancer for Metformin versus Sulphonylurea monotherapy in Type 2 Diabetes Mellitus: A propensity score-matched retrospective cohort study

  • Athena Yan Hiu Lee
  • , Jiandong Zhou
  • , Jeremy Man Ho Hui
  • , Xuejin Liu
  • , Teddy Tai Loy Lee
  • , Kyle Hui
  • , Abraham Ka Chung Wai
  • , Wing Tak Wong
  • , Tong Liu
  • , Kenrich Ng
  • , Sharen Lee
  • , Edward Christopher Dee
  • , Jeffrey Shi Kai Chan
  • , Qingpeng Zhang
  • , Gary Tse
    • Cardiovascular Analytics Group
    • City University of Hong Kong
    • University of Oxford
    • Diabetes Research Unit
    • The University of Hong Kong
    • Kaili University
    • Chinese University of Hong Kong
    • Tianjin Medical University
    • Kent Medway Medical School
    • Li Ka Shing Institute of Health Sciences

    Research output: Contribution to journalMeeting Abstractpeer-review

    2 Downloads (Pure)
    Original languageEnglish
    Pages (from-to)EPR22-112
    JournalJournal of the National Comprehensive Cancer Network
    Volume20
    Issue number3.5
    DOIs
    Publication statusPublished - 31 Mar 2022

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Keywords

    • Oncology

    Cite this